维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

14篇 您的检索式：作者名="FREIDING J"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Rosiglitazone and hepatic failure显示文摘	Everitt D Boscia J	2000	Ann Intern Med2000，132，18：	1
	2	Extrusion of zeolites:Properties of catalysts with a novel aluminium phosphate sintermatrix显示文摘	FREIDING J PACTAS F C KRAUSHAARCZARNETZKI B	2007	Applied Catalysis A:General2007，328，2：	1
	3	Novel extruded fixed-bed MTO catalysts with high olefin selectivity and high resistance against coke deactivation显示文摘	FREIDING J KRAUSHAAR-CZARNETZKI B	2011	Applied Catalysis A:General2011，391，12：	1
	4	Assessing the effects of bupropion SR on mood dinensions depression 显示文摘	Tomarken A J dichter GS Freid C	2004	J Affect Disord2004，78，3：	1
	5	Assessing the effects of bupropion SR on mood dinensions of depression显示文摘	TOMARKEN A J DICHTER GS FREID C	2004	J Affect Disord2004，78，3：	1
	6	Assessing the effects of bupropion SR on mood dimensions of depression 显示文摘	Tomarken A J Dichter GS Freid C	2004	J Affect Disord2004，78，3：	1
	7	Contribution of the NADH-oxidase (Nox) to the aerobic life of Lactobacilluss an franciscensis DSM20451T显示文摘	Jansch A Freiding S Behr J		0，，01：	1
	8	Rosiglitazone and hepatic failure 显示文摘	Freid J Everitt D Boscia J	2000	Ann Intern Med2000，132，18：	1
	9	Contribution of the NADH-oxidase (Nox) to the aerobic life of Lactobacillus sanfranciscensis DSM20451T 显示文摘	JANSCH A FREIDING S BEHR J	2011	Food Microbiology2011，28，1：	1
	10	Assessing the effects of bupropion SR on mood dimensions of depression显示文摘	Tomarken A J Dichter GS Freid C	2004	J Affect Disord2004，78，3：	1
	11	Assessing the effects of bupropion SR on mood dimensions of depression显示文摘	Tomarken A J Dichter GS Freid C	2004	J Affect Disord2004，78，3：	1
	12	Assessing the effects of bupropion SR on mood dimensions of depression显示文摘	Dichter GS Freid C	2004	J Affect Disord2004，78，3：	1
	13	Assessing the effects of bupropion SR on mood dimensions of depression显示文摘	Dichter GS Freid C	2004	J Affect Disord2004，78，3：	1
	14	Development of a CO_2 Tolerant Fischer-Tropsch Catalyst:from Laboratory to Commercial-Sca1e Demonstration in Alaska显示文摘This article describes the development of BP's Fischer-Tropsch catalyst, used for the conversion of carbon monoxide and hydrogen into liquid hydrocarbons. It covers the 18 year period from the early eighties, when laboratory scale preparations and micro-reactors were heavily used, right through to the present day with the commercial scale manufacture and proving of the finished catalyst in BP's new $86 million gas to liquids demonstration facility in Nikiski, Alaska. Extensive performance testing and scale-up experiments have been successfully carried out, all proof that a laboratory preparation can indeed be translated into a commercial manufacturing process. In addition, the resulting catalyst does not only meet the process design targets, but also exhibits enhanced stability and is tolerant to carbon dioxide.Above all, a commercial scale, fixed bed Fischer-Tropsch catalyst is now available and ready for licensing.Manufacturing procedures and quality control have all been successfully detailed and transferred to the commercial manufacturer.	Joep J H M Font Freide Tim D Gamlin J Richard Hensman Barry Nay Christopher Sharp	2004	Journal of Natural Gas Chemistry2004，13，1：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费